Pilot study of the efficacy of a psychosocial intervention for frequent parasuicide attempters with personality disturbance

ISRCTN ISRCTN28223466
DOI https://doi.org/10.1186/ISRCTN28223466
Secondary identifying numbers RDC00388
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
22/02/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Peter Tyrer
Scientific

St Mary's Hospital Medical School
Patterson Centre
20 South Wharf Road
London
W2 1PD
United Kingdom

Phone +44 (0)20 7886 1648
Email p.tyrer@ic.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesA pilot study will test the efficacy of a new psychological treatment for patients seen after an episode of deliberate self-harm (parasuicide or attempted suicide). The treatment is based on a self-treatment manual (suicide behaviour prevention manual) developed by us from previous work by Linehan and Davidson on the cognitive treatment of patients with borderline and anti-social personality disorder. Although the previous treatment has been shown to be successful in reducing episodes of deliberate self-harm it is very intensive and not suitable for general use. Our treatment comprises one session of explanation of the manual followed by a maximum of five further sessions of treatment using a psychoeducational and problem solving approach to suicide behaviour.

60 patients aged between 16 and 40 living in Paddington, Marylebone, Chelsea and Kensington will be seen after an episode of deliberate self-harm who have at least one previous suicide attempt in the past year and qualify for personality disturbance (either difficulty or disorder) in one of the flamboyant categories (histrionic, borderline, impulsive, anti-social). They will be randomised to treatment as usual or to the experimental group and treated for up to three months. Assessment of health service costs, suicide intent and acts, mood disturbance and social functioning will be made before randomisation and after six months by an independent research psychologist.

If the treatment is found to be successful an application will be made to the MRC for a larger study in a population with less restrictive entrance criteria.
Ethics approval(s)Not provided at time of registration.
Health condition(s) or problem(s) studiedMental and behavioural disorders: Other mental disorder
Intervention1. Psychological treatment using a psychoeducational and problem solving approach to suicide behaviour: manual-assisted cognitive-behaviour therapy (MACT)
2. Standard care
Intervention typeOther
Primary outcome measureThe main outcome measures will be the time of the next parasuicide act (using Linehan's definition of this, which is more minor than an actual suicide attempt). Our expectation is that our experimental treatment will extend this from a mean of three weeks to a mean of three months and this will require a sample size of 30 in each treatment group.
Secondary outcome measures1. Time to first suicidal act
2. Rate of suicidal acts
3. Change in anxiety and depressive symptoms
Overall study start date01/01/1996
Completion date31/12/1998

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants34
Key inclusion criteriaEfficacy of a new brief manualised form of cognitive behaviour therapy in those with personality disturbance within the flamboyant (cluster B) group. Thirty four patients were enrolled and 32 (18 MACT; 14 TAU) were seen at follow-up.
Key exclusion criteriaNot provided at time of registration.
Date of first enrolment01/01/1996
Date of final enrolment31/12/1998

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

St Mary's Hospital Medical School
London
W2 1PD
United Kingdom

Sponsor information

NHS R&D Regional Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Executive London (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/01/1999 Yes No